Koshinski Asset Management Inc. Decreases Holdings in Humana Inc. $HUM

Koshinski Asset Management Inc. cut its stake in shares of Humana Inc. (NYSE:HUM) by 8.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,326 shares of the insurance provider’s stock after selling 116 shares during the period. Koshinski Asset Management Inc.’s holdings in Humana were worth $324,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Cary Street Partners Investment Advisory LLC raised its stake in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after buying an additional 46 shares during the last quarter. Applied Finance Capital Management LLC raised its stake in Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock valued at $779,000 after buying an additional 48 shares during the last quarter. Blue Trust Inc. raised its stake in Humana by 3.6% during the 2nd quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after buying an additional 48 shares during the last quarter. Achmea Investment Management B.V. raised its stake in Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock valued at $2,746,000 after buying an additional 49 shares during the last quarter. Finally, Beech Hill Advisors Inc. raised its stake in Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after buying an additional 50 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on HUM. Bank of America boosted their target price on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Guggenheim reissued a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Barclays cut their price objective on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research report on Friday, October 3rd. Sanford C. Bernstein boosted their price objective on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Finally, Morgan Stanley cut their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus price target of $297.58.

Humana Trading Up 3.2%

Shares of Humana stock opened at $283.75 on Tuesday. The company has a market capitalization of $34.13 billion, a P/E ratio of 21.78, a P/E/G ratio of 1.61 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The company has a fifty day moving average of $280.87 and a 200 day moving average of $258.35. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s dividend payout ratio is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.